Ethics. Research. Community.

One of the World’s Largest Drug Makers is Paying Docs Again

And patients are the worse off. Ed Silverman writes, Seeking to recover from sensational marketing scandals, GlaxoSmithKline did something unexpected five years ago — the company promised it would no longer pay doctors to promote its medicines, which had been a long-standing industry practice

Login or register to tag items